Vitiligo

Vitiligo is a chronic pigment disorder in which functional melanocytes are lost from affected skin, leading to sharply defined white patches that can appear on the face, hands, scalp, body folds, or genital areas. Current research most strongly supports an immune-mediated process, especially in non-segmental vitiligo, with oxidative stress, genetic susceptibility, and local skin factors also contributing. The condition is not contagious and is often medically benign, but its visibility can create substantial emotional and social burden, particularly when lesions involve the face, hands, or darker skin tones.

Treatment options vary because vitiligo is highly individual: some people have small, stable patches, while others experience rapidly spreading depigmentation. Response also depends on body location, disease subtype, age, access to care, and goals such as halting spread versus encouraging repigmentation. In Western dermatology, common approaches include topical anti-inflammatory therapy, targeted or whole-body phototherapy, and newer topical immune-modulating options. In Eastern and integrative traditions, approaches such as acupuncture and Chinese herbal medicine are traditionally used to support systemic balance and stress regulation, though evidence quality is generally less robust and should be interpreted cautiously. Because treatment often unfolds over months, decisions usually involve balancing evidence strength, convenience, risk tolerance, cost, and how urgently disease activity needs to be controlled.